Cochrane Abstracts
Contrast‐enhanced ultrasound compared with computed tomography, magnetic resonance imaging, and positron emission tomography‐computed tomography for diagnosing liver metastases in people with newly diagnosed colorectal cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Contrast‐enhanced Ultrasound Compared With Computed Tomography, Magnetic Resonance Imaging, and Positron Emission Tomography‐computed Tomography for Diagnosing Liver Metastases in People With Newly Diagnosed Colorectal Cancer." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436063/all/Contrast‐enhanced_ultrasound_compared_with_computed_tomography__magnetic_resonance_imaging__and_positron_emission_tomography‐computed_tomography_for_diagnosing_liver_metastases_in_people_with_newly_diagnosed_colorectal_cancer.
Contrast‐enhanced ultrasound compared with computed tomography, magnetic resonance imaging, and positron emission tomography‐computed tomography for diagnosing liver metastases in people with newly diagnosed colorectal cancer. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436063/all/Contrast‐enhanced_ultrasound_compared_with_computed_tomography__magnetic_resonance_imaging__and_positron_emission_tomography‐computed_tomography_for_diagnosing_liver_metastases_in_people_with_newly_diagnosed_colorectal_cancer. Accessed March 15, 2025.
Contrast‐enhanced ultrasound compared with computed tomography, magnetic resonance imaging, and positron emission tomography‐computed tomography for diagnosing liver metastases in people with newly diagnosed colorectal cancer. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436063/all/Contrast‐enhanced_ultrasound_compared_with_computed_tomography__magnetic_resonance_imaging__and_positron_emission_tomography‐computed_tomography_for_diagnosing_liver_metastases_in_people_with_newly_diagnosed_colorectal_cancer
Contrast‐enhanced Ultrasound Compared With Computed Tomography, Magnetic Resonance Imaging, and Positron Emission Tomography‐computed Tomography for Diagnosing Liver Metastases in People With Newly Diagnosed Colorectal Cancer [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 15]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436063/all/Contrast‐enhanced_ultrasound_compared_with_computed_tomography__magnetic_resonance_imaging__and_positron_emission_tomography‐computed_tomography_for_diagnosing_liver_metastases_in_people_with_newly_diagnosed_colorectal_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Contrast‐enhanced ultrasound compared with computed tomography, magnetic resonance imaging, and positron emission tomography‐computed tomography for diagnosing liver metastases in people with newly diagnosed colorectal cancer
ID - 436063
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436063/all/Contrast‐enhanced_ultrasound_compared_with_computed_tomography__magnetic_resonance_imaging__and_positron_emission_tomography‐computed_tomography_for_diagnosing_liver_metastases_in_people_with_newly_diagnosed_colorectal_cancer
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
